12:01 PM EST - QLT Inc. : a global pharmaceutical company based in Vancouver, Canada, announced an exclusive license agreement with Reckitt Benckiser Pharmaceuticals Inc. for Atrigel sustained-release drug delivery technology for an upfront payment of US$25 million. QLT Inc.
shares T.QLT are trading up 2 cents at $4.03.
